The death receptor Fas transduces apoptotic death signaling mediated by caspases. In the present study, human hepatoma HepG2 cells showed the Fas-mediated apoptosis mediated by caspase, especially caspase 3, only in the presence of actinomycin D. Interestingly, cytosolic proteins extracted from intact HepG2 cells induced caspase 3 inactivation. Our results reveal that this inactivation was triggered by the direct inhibition of activated caspase 3 by IAP gene family ILP. In addition, a 53 kDa protein was co-immunoprecipitated with antihuman caspase 3 antibody from intact HepG2 cells. This protein was a complex-protein of procaspase 3 and the cell cycle regulator p21 WAF1 (p21). P21 bound to only procaspase 3, but not to activated caspase 3. We also demonstrate that p21 protein-loaded HepG2 cells resist to Fas-mediated apoptosis even in the presence of actinomycin D. Here we report that caspase 3 inactivation for the resistance to Fas-mediated apoptosis is induced by a procaspase 3/p21 complex formation and direct inhibition of activated caspase 3 by ILP.
Introduction
Programmed cell death is a physiological process indispensable for homeostatic maintenance of multicellular organisms most of which proceeds in an apoptotic fashion. Apoptotic cell death is accompanied by condensation and fragmentation of nuclei, loss of plasma membrane microvilli, condensation of cytoplasm, and fragmentation of chromosomal DNA into 180 bp oligomers and encountered in post embryonic and embryonic development (Wyllie et al., 1980; Buttyan et al., 1989) . Apoptosis also plays the dominant role in various physiological cell death and disease states (Nagata and Golstein 1995; Suzuki et al., 1996a ± c; Nagata, 1997) . Several factors involved in apoptosis have been identi®ed, some functioning to drive the death mechanism and others acting against apoptotic cell death.
The cell surface molecule Fas (APO-1/CD95; ref. Trauth et al., 1989) transduces the intracellular apoptotic death signaling upon stimulation by Fas ligand (Itoh et al., 1991; Suda et al., 1993; Nagata and Golstein, 1995) . Fas plays a dominant role in various physiological cell death and disease states (Nagata and Golstein, 1995; Suzuki et al., 1996a ± c) . Recent investigations for the Fas-initiated death signaling have revealed the direct involvement of the interleukin-1b converting enzyme (ICE)-like proteinase family (Enari et al., 1995) . The ICE gene shows close similarity to the ced-3 death gene derived from Caenorhabditis elegans (Yuan et al., 1993) . Ten genes have been identi®ed as ICE/CED-3 homologue and these were recently termed the`caspase' family (Alnemri et al., 1996) . Among caspases, an essential role of caspase 3 (CPP32/Yama/Apopain) in Fasmediated apoptosis has been reported (FernandesAlnemri et al., 1994; Hasegawa et al., 1996; Suzuki et al., 1997b) . Caspase 3 exists in the cytoplasm of intact cells as a proenzyme form and is activated by proteolysis induced by the stimulation of Fas (Hasegawa et al., 1996; Suzuki et al., 1997b) . Caspase 3 is the essential factor in Fas-initiated death signaling, since it directly induces the activation of DNA fragmentation factor (DFF and Liu et al., 1997) .
Some genes have also been identi®ed as the death suppressor. Bcl-2 oncoprotein was identi®ed originally through study of the t(14;18) translocation present in human B cell follicular lymphomas (Tsujimoto et al., 1984) . Recently, some genes showing high similarity to Bcl-2 have been identi®ed and termed the Bcl-2 family. Of these, Bcl-2 and Bcl-xL are unique in that they inhibit apoptosis rather than promoting cell proliferation (Vaux et al., 1988; Tsujimoto, 1989; Boise et al., 1993) . Overexpression of Bcl-2 partially prevented Fasmediated apoptosis (Itoh et al., 1993) . Fas shows two important domains in the cytoplasmic region, the death domain and the inhibitory domain (Itoh et al., 1991; Itoh and Nagata, 1993) . FAP-1, which was identi®ed as a death suppressor, also prevents Fas-mediated apoptosis by binding to the Fas-inhibitory domain (Sato et al., 1995) . Recently, the inhibitor-of-apoptosis (IAP) family genes have been identi®ed in animals ranging from insects to humans. The X-chromosomelinked IAP (ILP) has a unique function to suppress the apoptotic death signaling by the direct inhibition of caspase 3 (Deveraux et al., 1997) .
In the present study, we investigated Fas-mediated apoptosis initiated by caspase 3 using human hepatoma HepG2 cells. HepG2 cells showed the resistance to Fas-mediated apoptosis in the absence of the de novo protein synthesis inhibitor actinomycin D. We demonstrated that ILP-containing cytosolic protein from intact HepG2 cells induced caspase 3-inactivation. In addition, we also identi®ed cell cycle regulator p21 as the procaspase 3-binding protein, and p21-loaded HepG2 cells showed the resistance to Fas-mediated apoptosis even under the presence of actinomycin D. Here, we report the caspase 3 regulation by ILP and/or p21 during Fas-mediated apoptosis.
Results

Resistance to Fas-mediated apoptosis
The eect of an agonistic Fas antibody (Fas Ab; CH-11 clone and Yonehara et al., 1989) in human hepatoma HepG2 cells was examined. Apoptotic cell death is generally detected by its unique nuclear morphology, namely condensation and/or fragmentation of nuclei (Wyllie et al., 1980) , so nuclear morphology was observed by¯uorescence microscopy. The cell viability of each group was measured by Hoechst 33342/PI staining analysis (indicated by the ratio of intact nuclei in total nuclei and Hasegawa et al., 1996; Suzuki et al., 1997a, b) . When cells were treated with various concentration of Fas Ab in the presence of actinomycin D, a dose-dependent cytolytic activity was encountered (Figure 1 ). In contrast, HepG2 cells showed resistance to the Fas Ab agonistic activity in the absence of actinomycin D.
CPP32 subfamily during Fas-mediated apoptosis
To examine a direct involvement of the CPP32 subfamily in Fas-mediated apoptosis, the eect of a synthetic tetrapeptide inhibitor DEVD-CHO (Hasegawa et al., 1996; Suzuki et al., 1997b) on the activation of the CPP32 subfamily was investigated. When HepG2 cells showed Fas-mediated apoptosis upon stimulation by Fas Ab in the presence of actinomycin D, a drastic elevation of CPP32 subfamily activity ( Figure 2a ) and the death prevention by DEVD-CHO (Figure 2b ) were encountered. This data is con®rmed with previous results by Hasegawa et al. (1996) , in that Fas-mediated apoptosis in HepG2 cells is initiated by the CPP32 subfamily.
Death suppressor in HepG2 cells
To further examine the resistance to Fas-mediated apoptosis in HepG2 cells, expressions of Bcl-2, Bcl-xL and ILP were investigated. Immunoblotting analysis using speci®c antibodies revealed expression of ILP in intact HepG2 cells (Figure 3 ), but no expression of Bcl-2 or Bcl-xL (data not shown). ILP antigen was 
Caspase 3-inactivation by ILP
We further examined the involvement of ILP in the resistance encountered in HepG2 cells in the absence of actinomycin D. Due to the expression and essential role of caspase 3 (CPP32/Yama/Apopain) in HepG2 cells (Hasegawa et al., 1996) , we evaluated caspase 3 activity in this system. Caspase 3 activity were prevented by the addition of intact HepG2 cell extracts (Figure 4a ). Interestingly, caspase 3-inactivation by intact HepG2 cell extracts were encountered only with cytoplasmic proteins (Figure 4a) . Because the previous data demonstrated that intact HepG2 cell extracts contain ILP, ILP-free cell extracts were prepared by the addition of ILP antibody or immunoabsorption. ILP-free cell extracts could not suppress caspase 3 activity (Figure 4a ). ILP antibody was prepared by the immunization of GST-mycILP, and immunoblotting analysis to characterize this antibody revealed that the antibody recognized ILP (data not shown). In addition, GST-or Myc-free HepG2 cell extracts prepared by the immunoabsorption by each antibody could not suppress the caspase 3 activity (Figure 4a ). Therefore, we suggest that the inactivation of caspase 3 by HepG2 cell extracts is due to the direct eect of ILP.
We also performed OLP loading procedure (Suzuki et al., 1997a) to further examine the direct eect of ILP. When GST-ILP was loaded into HepG2 cells, the resistance to Fas-mediated apoptosis was encountered in the presence of actinomycin D. In contrast, GSTloaded HepG2 cells showed the Fas-mediated apoptosis in the presence of actinomycin D, same as intact HepG2 (Figure 4b ). These results suggest the direct inhibition of caspase 3 by ILP. Our ®ndings, therefore, are con®rmed with a previous report (Deveraux et al., 1997) .
Procaspase 3/p21 complex in HepG2 cells
The current data suggests that ILP directly suppresses caspase 3 activation. Therefore, we performed a coimmunoprecipitation study to examine whether ILP binds to caspase 3 in intact HepG2 cells. When caspase 3 was immunoprecipitated by its antibody, 53 kDa and 32 kDa proteins were encountered under non-reducing conditions, and the 53 kDa band disappeared under reducing conditions (Figure 5a ). Another band detected between 53K and 32K was anti-mouse IgG antibody (used as 2nd antibody)-reacted protein. In addition, ILP antibody did not react with material in the immunoprecipitates (data not shown). These results suggest that the 53 kDa protein is a heterocomplex of caspase 3 with other proteins. To identify the components, we examined expression of some cell death-associating factors with apparent molecular weight of about 20 ± 30 kDa. Among tested antibodies, an expression of p21 WAF1 (p21) was encountered in intact HepG2 cells and down-regulated by actinomycin D treatment (Figure 5b ). To examine whether p21 binds to caspase 3, co-immunoprecipitation analysis was performed, and the results strongly suggest binding of procaspase 3 and p21 (Figure 5c ). In addition, p21 bound to only procaspase 3 (Figure 5d ), but did not (c) Caspase 3 Ab-immunoprecipitates or p21 Ab-immunoprecipitates were separated on 5 ± 20% SDS ± PAGE under reducing condition, and then caspase 3 Ab-immunoprecipitates were detected by p21 Ab (caspase 3/p21) and p21 Ab-immunoprecipitates were detected by caspase 3 Ab (p21/caspase 3). Bars on the left side of each photograph show the positions of molecular weight marker: 97.4, 66, 46, 30 and 20.1 kDa from head to bottom. (d) Intact HepG2 cell extracts were mixed with GST-p21 proteins (GST-p21), and then GST-p21 proteins were collected by glutathione-beads. After collection, precipitates were separated on 5 ± 20% SDS ± PAGE under reducing condition and detected by caspase 3 Ab. As the control, intact HepG2 cell extracts were mixed with glutathione S-transferase-agarose (Glutathione). Bars on the left side of each photograph show the positions of molecular weight marker: 97.4, 66, 46, 30 and 20.1 kDa from head to bottom. (e) Eect of p21 on activated caspase 3. Proteolytic activity of caspase 3 in control E. coli extracts (DE3), E. coli extracts containing with activated caspase 3 (Caspase 3) or mixture of GST-p21 and activated caspase 3-containing E. coli extracts were measured aect activated caspase 3 (Figure 5e ). Taken together, our results suggest that the p21 cell cycle regulator interacts only with procaspase 3.
Resistance to Fas-mediated apoptosis by procaspase 3/p21 complex
The above data demonstrates procaspase 3/p21 complex formation in intact HepG2 cells. To examine whether this complex formation is essential for the resistance to Fas-mediated apoptosis, we loaded GSTp21 into HepG2 cells with the OLP loading procedure (Suzuki et al., 1997a) . When GST-p21 was loaded into HepG2 cells, the resistance to Fas-mediated apoptosis was encountered even in the presence of actinomycin D (Figure 6a and b) . In addition, the immunoblotting procedure revealed the activation of caspase 3, namely the molecular shift of procaspase 3, in the GST-loaded HepG2 cells treated with Fas Ab in the presence of actinomycin D (Figure 6c ). In contrast, Fas Ab treatment did not induce the molecular shift of procaspase 3 in GST-p21-loaded HepG2 cells. Our present results strongly suggest that p21 also acts as the death suppressor by the complex formation with procaspase 3.
Discussion
The death receptor Fas transduction of apoptotic death signaling upon stimulation by Fas ligand or agonistic Fas Ab, plays essential roles in various physiological cell death and disease states (Nagata and Golstein, 1995; Suzuki et al., 1996a ± c; Nagata, 1997) . This receptor protein localizes on the cell surface of various cell lines (Nagata and Golstein, 1995; Nagata, 1997) . Many investigations of Fas-mediated apoptosis have been initiated to clarify its molecular mechanisms using various cells. Interestingly, some cell lines show Fasmediated apoptosis only under the presence of actinomycin D which inhibits de novo protein synthesis by inhibition of mRNA transcription. In the present study, we also investigated the molecular mechanisms of Fas-mediated apoptosis using human hepatoma cell line HepG2 cells.
As in the previous report by Hasegawa et al. (1996) , we ®rst induced Fas-mediated apoptosis in HepG2 cells using an agonistic Fas Ab (CH-11 clone and Yonehara et al., 1989) in the presence of actinomycin D. Fas Abtreatment in the presence of actinomycin D induced nuclear condensation and/or fragmentation in HepG2 cells (data not shown) as shown previously (Hasegawa et al., 1996) . When HepG2 cells were treated with Fas Ab in the presence of actinomycin D, a drastic decrease in cell viability was encountered in a dose-dependent manner. Interestingly, this Fas-mediated apoptosis was not encountered in the absence of actinomycin D. Many reports revealed the apoptotic cell deathinduction by actinomycin D alone, however, 0.5 mg/ ml actinomycin D (experimental condition in the previous report by Hasegawa et al. (1996) and our present study) did not induce apoptotic cell death in HepG2 cells (data not shown). In addition, actinomycin D alone did not show any eect in expressions of death factors, Fas, FADD, caspase 8 (FLICE/MACH) and caspase 3 (data not shown). These results, therefore, led us to the possible presence of endogenous suppressor of Fas-mediated apoptosis in HepG2 cells.
Before the identi®cation of the endogenous suppressor of Fas-mediated apoptosis, we further examined the characteristics of Fas-mediated apoptosis in HepG2 cells to con®rm with the previous report (Hasegawa et al., 1996) . Caspase is a nomenclature of ICE/CED-3 family of cysteinproteinases (Alnemri et al., 1996) . Three subfamilies of caspase have been documented and are known as the ICE-, CPP32-and ICH-1-subfamilies. An essential role of caspase in Fasinitiated death signaling has been demonstrated (Nagata, 1997), especially for the CPP32 subfamily which acts as the dominant death mediator in Fasmediated apoptosis of HepG2 cells (Hasegawa et al., 1996) . As in previous reports, the elevation in CPP32 subfamily activity and the Fas-mediated apoptosis prevention by CPP32 subfamily inhibitor DEVD-CHO were encountered in HepG2 cells. These data also support the essential role of CPP32 subfamily in Fas-mediated apoptosis of HepG2 cells and the presence of an endogenous suppressor of Fasmediated apoptosis.
Recently, various death-associated genes have been identi®ed, some functioning to drive the death mechanism and others acting against apoptotic cell death. Among factors acting against apoptotic death signaling, we examined the possible involvement of the Bcl-2 family, IAPs and Fas-associated proteins. Fas contains two unique domains in the cytoplasmic region, the death domain and the inhibitory domain (Itoh et al., 1991; Itoh and Nagata, 1993) . Two proteins have been identi®ed as the Fas-associated proteins: FAP-1 interacts with the inhibitory domain (Sato et al., 1995) and FLIP interacts with the death domain (Irmler et al., 1997) . FAP-1 prevents the apoptotic death signaling by binding to the inhibitory domain of Fas, but its expression is not encountered in HepG2 cells (Sato et al., 1995) . In the current study, there was no dierences in co-immunoprecipitates with Fas Ab between HepG2 cells treated with or without actinomycin D (data not shown). This suggests that the FAP-1 and FLIP Fas-associated proteins are not involved with the resistance encountered in HepG2 cells in the absence of actinomycin D and that the endogenous suppressor does not interact with Fas. Immunoblotting analysis was performed to examine the possible involvement of the Bcl-2 family and IAPs. Among Bcl-2 family members, Bcl-2 and Bcl-xL suppress the apoptotic death signaling (Tsujimoto et al., 1984; Vaux et al., 1988; Tsujimoto, 1989; Boise et al., 1993) , whereas those expressions were not encountered in intact HepG2 cells (data not shown). IAPs also prevent the apoptotic death signaling, and especially ILP can suppress it by direct inhibition of caspase 3 (Deveraux et al., 1997) . In the present study, ILP expression was encountered in intact HepG2 cells, and its expression was down regulated by treatment with actinomycin D. These results led us to the possible involvement of ILP in the resistance of Fas-mediated apoptosis in the absence of actinomycin D.
To further examine the possible involvement of ILP in the resistance of HepG2 cells, an eect of various proteins in the enzymatic activity of recombinant caspase 3 was investigated. Recombinant caspase 3 (active form) showed the high DEVD-MCA cleaving activity, but its activity was down regulated by the addition of cytoplasmic proteins of intact HepG2 cells. These results suggest that the endogenous suppressor of Fas-mediated apoptosis localizes in the cytoplasmic fraction of HepG2 cells and directly inhibit the activation of caspase 3. This direct inhibition of activated caspase 3 was close similar to ILP activity (Deveraux et al., 1997) . We demonstrated three evidences: (1) ILP expression in intact HepG2 cells; (2) ILP-free cell extracts could not suppress the caspase 3 activity; (3) GST-ILP-loaded HepG2 cells showed the resistance to Fas-mediated apoptosis. These results support the conclusion that ILP prevents Fas-mediated apoptosis by direct interaction with activated caspase 3.
To examine whether ILP binds directly to caspase 3, co-immunoprecipitation analyses were performed. When intact HepG2 cell extracts were co-immunoprecipitated with caspase 3 Ab, two proteins were detected under non-reducing conditions. One was a 32 kDa protein suggesting procaspase 3 on the basis of molecular weight, and another was a 53 kDa protein which disappeared under reducing conditions. Because the 53 kDa protein in the caspase 3 Ab-immunoprecipitates did not react with ILP Ab, it became possible that the 53 kDa protein band represented a complex of procaspase 3 with an unknown protein(s). Among the various antibodies used for subsequent immunoblotting studies, antibody for the p21 WAF1 cell cycle regulator showed p21 expression in intact HepG2 cells. Cell cycle regulation is also a physiological process indispensable for homeostatic maintenance of multicellular organism. Recent progressive investigation revealed various cell cycle regulator. Cell cycle regulator p21 acts as the inhibitor by the binding to cyclin-dependent kinase 4 (Cdk4)/proliferating cell nuclear antigen (PCNA) complex protein (Xiong et al., 1993; Li et al., 1994) . So, the estrangement of p21/Cdk4/PCNA complex induces the cell cycle entry. Our results led us to the possibility that procaspase 3 forms a complex with p21 in intact HepG2 cells. When caspase 3 Ab-immunoprecipitates were exposed to p21 Ab, the immunostained band was detected at 53 kDa. In addition, p21 Ab-immunoprecipitates reacted with caspase 3 Ab at 53 kDa. Interestingly, p21 interacted with only procaspase 3, but not with activated caspase 3. During Fas-mediated apoptosis, the ®rst step of caspase 3 activation is the cleaving at p3 site (Suzuki et al., 1997b) . So, p21 may bind to the p3 site of procaspase 3. On the basis of our present results, we indicate that procaspase 3 forms a complex with p21, but ILP interacts only with activated caspase 3. These studies demonstrated a direct binding interaction between procaspase 3 and p21. To examine whether p21 could interact biologically with procaspase 3, p21 proteins were loaded into HepG2 cells using the OLP loading procedure. As indicated above, Fas-mediated apoptosis was induced in the HepG2 cells only in the presence of actinomycin D. When p21 proteins were loaded into HepG2 cells, p21-HepG2 hybrid cells showed resistance to Fas Ab even in the presence of actinomycin D. In addition, loaded p21 suppressed the activation of caspase 3 (the molecular shift of procaspase 3). These results indicated that p21 directly binds to procaspase 3 and prevents Fas-mediated apoptosis. Thus, these studies support the conclusion that the procaspase 3/p21 complex is an integral component in the resistance to Fas-mediated apoptosis.
In the present study, we demonstrated that the resistance to Fas-mediated apoptosis in human hepatoma HepG2 cells is triggered by procaspase 3/ p21 complex formation and the direct inhibition of activated caspase 3 by ILP. On the basis of our ®ndings, we hypothesize the interaction between`cell death' and`cell survival' as follows (Figure 7) . Death receptor Fas transduces the apoptotic death signaling by the binding of Fas ligand (Nagata and Golstein, 1995; Nagata, 1997) . The apoptotic death signaling triggered by the operation of Fas ligand/Fas system initiated by Fas-DISC (Kischkel et al., 1995) and ICE cascade (Enari et al., 1996) to activate caspase 3. The Fas-initiated death signaling is endogenously prevented by the p21-binding to procaspase 3, namely procaspase 3/p21 complex. The complex protein leads to`cell survival'. In addition, p21 binds to cell cycle entrystimulating factor, Cdks or PCNA, to also lead`cell survival' induced by cell cycle arrest. Thus, the procaspase 3/p21 complex formation is the ®rst resistance-machinery. If procaspase 3 is activated by the proteolysis by SP26 (Suzuki et al., 1997b) , its activation can be suppressed by the binding of ILP to activated caspase 3. The activated caspase 3/ILP complex formation also lead to`cell survival'. These death suppressors, p21 and ILP, were down-regulated by the actinomycin D treatment, and Fas-initiated death signaling could lead`cell death'. Therefore, we suggest that these down-regulation may be induced by some unknown stimulation to lead`cell death' as a result of`cell survival' suppression. Thus, we propose that two independent cell phenomenon, cell death and cell survival, are regulated by the valance of each independent signal transduction pathway.
Materials and methods
Cell lines
Human hepatoma HepG2 cells were supplied by Dr Yoshihide Tsujimoto (Hasegawa et al., 1996) , and were maintained in RPMI-1640 medium (Gibco BRL, MD, USA) supplemented with 10% heat-inactivated fetal calf serum (FCS; Gibco BRL) in a humidi®ed atmosphere of 5% CO 2 and 95% air.
Peptides and chemicals
DEVD-MCA and DEVD-CHO were purchased from Peptide Lab. (Osaka, Japan). As the agonistic Fas antibody (Fas Ab), the CH-11 clone was purchased from MBL Japan (Nagoya).
Assay of cell viability
Cell viability of each group was assessed by the Hoechst 33342 staining procedure as previously described (Hasegawa et al., 1996) with some modi®cations (Suzuki et al., 1997a,b) . Hoechst 33342 was purchased from Molecular Probes, Inc. (OR, USA). After stimulation by Fas Ab, cells were collected and stained with Hoechst 33342 and then observed by¯uorescence microscopy. Cell viability was indicated by the ratio of cells carrying intact nuclei to total cells (about 5000 cells).
Preparation of anti-human ILP antibody
pGEX5X-3 was digested by BamHI, blunted by Klenow and then self-ligated. Resulting plasmid was named pGEX5X-3'. The myc-epitope tagged ILP cDNA (pcDNAs-mycILP) was kindly donated from Dr CB Thompson (Duckett et al., 1996) . A mycILP fragment was isolated by EcoRI digestion, and then was subcloned into pGEX5X-3'. GST-mycILP was expressed in E. coli and puri®ed by Glutathione Sepharose 4B columns. Antigen emulsion was made from protein (100 mg) and complete Freund adjuvant (for primary immunization) or incomplete Freund adjuvant (for booster immunization) by using ultrasonicator. Female 8-week-old Balb/c mice were immunized subcutaneously. Booster immunization were given 2 and 5 weeks later and then blood was collected 1 week after the ®nal booster immunization.
Preparation of bacterial lysate expressing caspase 3 protein
The preparation of bacterial lysate expressing caspase 3 proteins was essentially as described by Xue et al. (1996) . Plasmid pET21b-hcpp32-His6 clone was kindly donated by Dr HR Horvitz (Xue et al., 1996) .
Preparation of GST-p21
Plasmid encoding GST or GST-murine p21 were transformed into E. coli and GST fusion proteins were puri®ed on glutathione sepharose (Pharmacia Biotech. AB, Uppsala, Sweden). pGST-p21 was provided by Dr Hitoshi Matsushime (Homan La-Roche, Inc., NJ, USA).
Preparation of cell extracts and assay of enzyme
Preparation of cell extracts and assay of enzyme was performed as previously described (Hasegawa et al., 1996) with some modi®cations (Suzuki et al., 1997a,b) . Cells were collected, washed with PBS and suspended in PBS-EDTA (pH 7.4). After the addition of 10 mM digitonin (Sigma), cells were incubated at 378C for 10 min. Lysates were collected by centrifugation (15 000 r.p.m./5 min) and total protein concentration was determined using a DC protein assay kit (Bio Rad, CA, USA). For enzyme assay, aliquots were incubated with 10 ml DEVD-MCA (50 mM) and the release of amino-4-methylcoumarin was monitored with a spectro¯uorometer. One unit was de®ned as the amount of enzyme required to release 0.22 nmol AMC per min at 378C
Protein extraction
Proteins were prepared for immunoblotting and immunoprecipitation analysis by lysis of cells with 1% NP-40 containing buer for 30 min. All procedures were carried out at 48C. Proteins were collected by the centrifugation at 15 000 r.p.m. for 15 min. Protein concentrations were determined by a method described previously (Smith et al., 1985; Hill and Sraka, 1988) using DC protein assay kit (Bio-Rad) with bovine serum albumin as standard.
Immunoprecipitation analysis
Anti caspase 3 antibody (Transduction Lab., KY, USA) or anti p21 antibody (Santa Cruz, CA, USA) was mixed with 1 mg protein from each cell extracts for 30 min. After mixture, protein A-sepharose was added and incubated for 2 h. The immunoprecipitates were heated in SDS sample buer and separated on 5 ± 20% polyacrylamide gels. After transfer, the membranes were immunoblotted, washed with Tween-PBS and developed using the ECL system (Amersham, Buckinghamshire, UK).
Immunoblotting analysis
Sample proteins separated by SDS ± PAGE were transferred onto nitrocellulose membranes by a semi-dry blotting system. The membranes were blocked with PBS containing 5% (w/v) skim milk (Snow Brand, Sapporo, Japan) at room temperature for 1 h, washed with a mixture of PBS and 0.05% Tween 20 (Sigma, Tween-PBS) and then incubated overnight at room temperature with each antibody diluted with PBS. After washing with Tween-PBS, the membranes were incubated with a 1000-fold diluted biotinylated anti-mouse IgG antibody (Bio Source, CA, USA), washed with Tween-PBS, and then incubated with avidin-HRP (Vector Lab., CA, USA) at room temperature for 1 h. The membranes were washed with Tween-PBS and then developed with the ECL system.
Preparation of nuclear-, membrane-and cytosol-rich proteins
Each cellular fraction was collected as previously described (Suzuki et al., 1997b) . Cells were collected and washed with ice-cold PBS, and then suspended in buer I (2 mM EDTA and 10 mM Tris-HCl, pH 7.5). After incubation on ice for 10 min, an equal volume of buer II (0.5 M Sucrose, 0.1 M KCl, 10 mM MgCl 2 2 mM CaCl 2 2 mM EDTA, 10 mM TrisHCl, pH 7.5) was added. The nuclear-rich fraction was collected as a pellet by centrifugation (2700 r.p.m./10 min); the supernatant was removed to other tube and separated by centrifugation (43 000 r.p.m./90 min). After centrifugation, the supernatant was collected as the cytosol-rich fraction, and the pellet was dissolved in buer III (8 mM CHAPS; 150 mM NaCl, 0.1 M Sucrose, 2 mM EDTA, 10 mM Tris-HCl, pH 7.5) and incubated at 48C for 2 h. The membrane-rich fraction was then collected by centrifugation (43 000 r.p.m./60 min).
Loading of GST-ILP or GST-p21 into HepG2 cells
For the loading of GST-ILP or GST-p21 proteins into HepG2 cells, the OLP loading procedure (Williams and Henkart, 1994) was used for experiments with some modi®cations (Suzuki et al., 1997a) . After the loading of GST-ILP or GST-p21 into HepG2 cells, cells were reacted with 1 mg/ml Fas Ab for 24 h in the presence of 0.5 mg/ml actinomycin D and death induction was examined by Hoechst 33342 staining analysis.
